STOCK TITAN

OVATION SCIENCE INC - OVATF STOCK NEWS

Welcome to our dedicated page for OVATION SCIENCE news (Ticker: OVATF), a resource for investors and traders seeking the latest updates and insights on OVATION SCIENCE stock.

Ovation Science Inc. (OVATF) is a research and development company specializing in topical and transdermal CBD/THC and other cannabinoid products. Leveraging its patented Invisicare® skin delivery technology, Ovation develops proprietary medical and wellness products that are distributed under its own brands, including ARLO CBD Beauty and InVibe® MD. With over 20 years of pharmaceutical drug delivery experience, Ovation has built a unique pipeline of over thirty products, along with anti-aging and beauty formulas. The company earns revenue through royalties on licensees' sales, sales of Invisicare, and its own product sales.

Rhea-AI Summary

Ovation Science announces the launch of its patented transdermal cannabis products in Pennsylvania through licensee PA Options for Wellness. This marks Ovation's second US licensee, targeting a market with over 850,000 registered patients and caregivers across 170+ dispensaries. PA Options, operating six dispensaries under Vytal Options brand with 32,000 registered medical patients, will distribute Ovation's products under the 'Mood' brand.

The company's formulations utilize Invisicare® technology, showing 10 times greater CBD release through the skin compared to other tested products. Ovation is expanding its US presence, with ongoing operations in Nevada through Planet 13 and planned entry into Missouri via MidWest Roots in January 2025. The company has terminated its licensing agreement with Stash House Distribution for Oklahoma, New Mexico, and Mississippi.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-64.81%
Tags
none
-
Rhea-AI Summary

Ovation Science Inc. announced the launch of its topical product line in Nevada with Planet 13 Holdings, Inc., featuring both cannabis and hemp-derived products. The partnership aims to expand brand presence and generate revenue for both companies. Ovation's proprietary skin delivery technology, Invisicare®, enhances product effectiveness, with significant CBD release compared to competitors. Planet 13's topicals include various ratios of CBD and THC for relaxation, relief, and recovery. The companies are optimistic about driving growth and optimizing gross margins through this collaboration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Ovation Science Inc. signs an exclusive licensing agreement with Ripco Processing Inc. for its cannabis products in Canada. Ripco will handle regulatory, manufacturing, marketing, and distribution activities, with Ovation receiving royalties. The agreement allows Ovation to launch its InVibeMD product line in early Q3 of 2024, expanding its market presence and revenue potential.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18%
Tags
none
Rhea-AI Summary
Ovation Science USA Inc. has signed an exclusive licensing agreement with MidWest Roots, LLC for its topical/transdermal cannabis formulations in Missouri. MidWest will handle regulatory, manufacturing, marketing, sales, and distribution activities, while Ovation will receive royalty income. Missouri is one of the largest cannabis markets, with over 200 dispensaries and $1.3 billion in sales as of August 2023. MidWest, known for its expertise in cannabis and consumer goods, plans to launch Ovation's products in late Q4 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
40.35%
Tags
none
-
Rhea-AI Summary
Ovation Science signs license agreement with Planet 13 for its topical/transdermal cannabis products for Nevada
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Ovation Science Inc. has announced a new Supply and Distribution Agreement with Golfer's CBD Ltd. for its CBD topical products in the USA, UK, and Europe. This partnership aims to penetrate the lucrative golf market, which includes approximately 66.6 million golfers worldwide. By leveraging Golfer's CBD's established e-commerce and retail distribution channels, Ovation expects to generate immediate monthly revenues. Their patented skin delivery technology, Invisicare, allows for superior absorption of cannabinoids, giving Ovation a competitive edge. The initial launch in the USA is scheduled for April 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Ovation Science Inc. (CSE: OVAT, OTCQB: OVATF) will exhibit at the MJ Unpacked conference from September 28-30, 2022, in Las Vegas. The company aims to meet potential licensees to promote its award-winning transdermal formulations and highlight licensing opportunities for its patented skin delivery technology, Invisicare®. With new patent protection until 2041 and expansion in states like Oklahoma and Missouri, Ovation anticipates significant interest in its products. CEO Terry Howlett emphasized the company's focus on effective cannabinoid delivery and the unique advantages of their formulations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Ovation Science Inc. has been awarded a patent for its transdermal creams formulated with CBD and THC, valid until February 2041. This patent strengthens the company's market position by protecting its proprietary drug delivery system, Invisicare. It covers the composition and method for delivering CBD and THC through the skin. Ovation has also expanded its licensing to four additional U.S. states, increasing its market reach to over 2,800 dispensaries. The company’s innovative approach has resulted in products showing significantly better absorption rates compared to competitors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Ovation Science Inc. has announced an exclusive licensing agreement with Stash House Distribution to expand its cannabis formulations into Oklahoma, Missouri, New Mexico, and Mississippi. This agreement aims to increase the company's market presence from 92 dispensaries in Nevada to over 2,800 dispensaries across five states. Ovation's products utilize the patented Invisicare® technology for enhanced cannabinoid delivery, promising a significant increase in revenue through royalties based on wholesale sales. The launch is expected to occur in Q4 of 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of OVATION SCIENCE (OVATF)?

The current stock price of OVATION SCIENCE (OVATF) is $0.0101 as of December 4, 2024.

What is the market cap of OVATION SCIENCE (OVATF)?

The market cap of OVATION SCIENCE (OVATF) is approximately 879.7K.

What is Ovation Science Inc.?

Ovation Science Inc. is a research and development company that focuses on developing topical and transdermal CBD/THC and other cannabinoid products.

What skin delivery technology does Ovation use?

Ovation leverages its patented Invisicare® skin delivery technology to enhance the delivery of ingredients to and through the skin.

How does Ovation earn revenue?

Ovation earns revenue through royalties on licensees' sales, sales of Invisicare, and its own product sales.

What brands are associated with Ovation?

Ovation distributes products under its own brands, including ARLO CBD Beauty and InVibe® MD, in addition to its proprietary medical and wellness products.

What is the mission of Ovation Science Inc.?

Ovation's mission is to build a recognizable global brand known for world-class dispensary operations and innovative cannabis products.

What distinguishes Ovation's products from competitors?

Ovation's products offer substantially higher CBD and THC delivery through the skin, resulting in better outcomes for patients compared to competitor products.

OVATION SCIENCE INC

OTC:OVATF

OVATF Rankings

OVATF Stock Data

879.68k
34.52M
2.06%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Vancouver